Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme - Möhler, Markus; Ebert, Matthias (European journal of cancer, 2014)